Skip to main content
OpenTrials
Completed

NCT Number: NCT00565422

Efficacy of Escitalopram in the Treatment of Internet Addiction

The purpose of this study was to determine whether Lexapro (Escitalopram) is safe and effective in treating problematic internet use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

About this study

Many individuals experience marked distress and functional impairments as a result of their perceived inability to control their 'non-essential' (non-job/school related) use of the Internet. Frequently these people develop a preoccupation with the Internet, a need for escape to the Internet, and increasing irritability when trying to cut back use of the Internet. There have been no studies to date looking at the effectiveness of medications in the treatment of this disorder. In our clinical experience, we find these patients with Internet addiction usually respond to serotonin reuptake inhibitors within 12 weeks. This study will examine the efficacy of escitalopram in Internet addiction among adults.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject has signed an informed consent form
  • Current diagnosis of Internet addiction
  • Age ³ 18
  • Subject must be able to take oral medication
  • Subject may be in psychotherapy initiated at least three months prior to Screening. Subject must not discontinue or otherwise alter this therapy during the study.
  • In the opinion of the investigator, the subject is capable of complying with all study procedures.

Exclusion criteria

  • Current suicidal or homicidal ideation
  • Subject has a primary diagnosis of schizophrenia or other psychotic disorders
  • Subject has a primary diagnosis of Bipolar I disorder
  • Current pedophilia
  • Current DSM-IV diagnosis of substance dependence or abuse, excluding nicotine
  • Women of child-bearing potential who are pregnant, nursing, or not using contraception
  • Use of antidepressants at a therapeutic level for the treatment of problematic internet use within 2 weeks prior to study entry (or 4 weeks for use of MAOIs, or 6 weeks for use of fluoxetine)
  • Current use of antidepressants at a therapeutic level for the treatment of a disorder other than problematic internet use
  • Subject has any organic mental disorder
  • Clinically significant unstable medical disorder

Treatment and study plan

Escitalopram

Drug

10 mg/day

Other names: Lexapro

Primary outcomes

  1. length of non-essential Internet use in hours/week as well as CGI-Improvement

    Time frame: baseline and biweekly for 10 weeks

Secondary outcomes

  1. ratings on depression, anxiety, impulsivity, self-esteem, obsessive-compulsive symptoms

    Time frame: baseline and biweekly for 10 weeks

Sponsors and collaborators

Lead sponsor

Icahn School of Medicine at Mount Sinai

Other

Collaborators

  • Forest Laboratories

Registry information

Important dates

Study start
2002
Study completion
2004
First posted
Nov 30, 2007
Registry last updated
May 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.